← SynDRA
IBROLIPIM
SynDRA canonical compound SYN0001807 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | LPL |
| Mechanism of action | lipoprotein lipase activator |
All known targets
Mechanisms of action (all sources)
- lipoprotein lipase activator
- LPL MODULATOR
Drug classes
- Hypolipidemic Agents
- Lipoprotein Lipase Activators
Cross-references
Synonyms
- NO-1886
- OPF-009
- OPF009
- Ibrolipim < Prop INN
- 4-[N-(4-Bromo-2-cyanophenyl)carbamoyl]benzylphosphonic acid diethyl ester
- NO 1886
- OPF 009
- ibrolipimum
- RefChem:789641
- DTXCID2080480
- Ibrolipim [USAN:INN]
- C19H20BrN2O4P
- Ibrolipi
- Ibrolipim?
- KPRTURMJVWXURQ-UHFFFAOYSA-N
- Ibrolipim [USAN]
- UNII-07H1561618
- IBROLIPIM [INN]
- Ibrolipim (USAN/INN)
- MLS006011667
- SCHEMBL493918
- orb1299465
- MFCD00897807
- AKOS005067076
- SS-3273
- NCGC00481428-01
- DA-64352
- SMR002529695
- HY-117549
- CS-0066427
- NS00116048
- T7832
- D03747
- D83803
- F812054
- BRD-K62490786-001-01-1
- Diethyl4-((4-bromo-2-cyanophenyl)carbamoyl)benzylphosphonate
- ایبرولیپیم
Look up IBROLIPIM in the interactive SynDRA portal →